MOTIVATE 2
Title:
Assessing Adherence among HIV-Positive Pregnant and Postpartum Women on Anti-Retroviral Therapy in Kenya: A Sub-Study of the Mother and Infant Visit Adherence and Treatment Engagement (MOTIVATE) Study
Acronym:
MOTIVATE 2
Timeline:
2017 – 2019
Status:
Completed
Site Principal Investigators:
- Dr. Lisa Abuogi,
- Dr. Janet Molzan Turan,
- Dr. Thomas Odeny
Objective:
A sub-study of the broader MOTIVATE trial focusing on adherence to ART during pregnancy and postpartum. The study assessed patterns, challenges, and facilitators of ART adherence among women in maternal and child health programs, revealing critical gaps in adherence support and informing interventions to improve maternal retention and treatment engagement in PMTCT settings.